IL162692A0 - Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol - Google Patents

Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol

Info

Publication number
IL162692A0
IL162692A0 IL16269202A IL16269202A IL162692A0 IL 162692 A0 IL162692 A0 IL 162692A0 IL 16269202 A IL16269202 A IL 16269202A IL 16269202 A IL16269202 A IL 16269202A IL 162692 A0 IL162692 A0 IL 162692A0
Authority
IL
Israel
Prior art keywords
formulations
propofol
water
aqueous based
pharmaceutical formulations
Prior art date
Application number
IL16269202A
Other languages
English (en)
Original Assignee
Guilford Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilford Pharm Inc filed Critical Guilford Pharm Inc
Publication of IL162692A0 publication Critical patent/IL162692A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16269202A 2001-12-28 2002-12-26 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol IL162692A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34275501P 2001-12-28 2001-12-28
PCT/US2002/041468 WO2003057153A2 (en) 2001-12-28 2002-12-26 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol

Publications (1)

Publication Number Publication Date
IL162692A0 true IL162692A0 (en) 2005-11-20

Family

ID=23343142

Family Applications (3)

Application Number Title Priority Date Filing Date
IL16269202A IL162692A0 (en) 2001-12-28 2002-12-26 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
IL162692A IL162692A (en) 2001-12-28 2004-06-23 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
IL208697A IL208697A0 (en) 2001-12-28 2010-10-14 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL162692A IL162692A (en) 2001-12-28 2004-06-23 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
IL208697A IL208697A0 (en) 2001-12-28 2010-10-14 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol

Country Status (22)

Country Link
US (1) US20050042280A1 (xx)
EP (1) EP1458355B1 (xx)
JP (2) JP2005517679A (xx)
KR (2) KR20040080444A (xx)
CN (1) CN1329036C (xx)
AT (1) ATE430571T1 (xx)
AU (1) AU2002364238B2 (xx)
BR (1) BR0215303A (xx)
CA (1) CA2470500C (xx)
DE (1) DE60232271D1 (xx)
ES (1) ES2325918T3 (xx)
HK (1) HK1069976A1 (xx)
HU (1) HU229293B1 (xx)
IL (3) IL162692A0 (xx)
MX (1) MXPA04006325A (xx)
NO (1) NO334424B1 (xx)
NZ (1) NZ533536A (xx)
PL (1) PL205271B1 (xx)
RU (1) RU2316317C2 (xx)
UA (1) UA76802C2 (xx)
WO (1) WO2003057153A2 (xx)
ZA (1) ZA200404616B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004286814A1 (en) 2003-10-24 2005-05-19 Auspex Pharmaceuticals, Inc. pH sensitive prodrugs of 2,6-diisopropylphenol
US7589239B2 (en) 2005-09-02 2009-09-15 Auspex Pharmaceuticals Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
EP2068630A4 (en) * 2006-10-05 2010-12-29 Eisai Inc AQUEOUS PHARMACEUTICAL FORMULATIONS OF WATER SOLUBLE PRODRUGS OF PROPOFOL
EP2152651B1 (en) 2007-05-09 2012-01-04 Pharmacofore, Inc. Therapeutic compounds
WO2008141097A2 (en) 2007-05-09 2008-11-20 Pharmacofore, Inc. Stereoisomers propofol therapeutic compounds
US20090098209A1 (en) * 2007-10-15 2009-04-16 University Of Kansas Pharmaceutical compositions containing water-soluble derivatives of propofol and methods of administering same via pulmonary administration
GB0905834D0 (en) 2009-04-03 2009-05-20 Seps Pharma Nv Phosphonyl-containing phenolic derivatives useful as medicaments
UY34072A (es) 2011-05-17 2013-01-03 Novartis Ag Derivados sustituidos de indol
CN110063947A (zh) * 2018-01-24 2019-07-30 四川海思科制药有限公司 苯酚衍生物用于制备***物中的用途
US11439653B1 (en) 2021-03-30 2022-09-13 Epalex Corporation Fospropofol formulations
US11628178B2 (en) 2019-03-26 2023-04-18 Epalex Corporation Fospropofol methods and compositions
US11478490B1 (en) 2021-03-30 2022-10-25 Epalex Corporation Fospropofol formulations
US11547714B2 (en) 2020-02-05 2023-01-10 Epalex Corporation Fospropofol salts, methods and compositions
JP2022108079A (ja) * 2021-01-12 2022-07-25 日本光電工業株式会社 生体情報処理装置、生体情報処理方法、プログラム及び記憶媒体
CN114129578A (zh) * 2021-09-28 2022-03-04 瑞普（天津）生物药业有限公司 甲磷丙泊酚钠在制备宠物麻醉、镇静药物中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2829151A (en) * 1952-11-03 1958-04-01 Dow Chemical Co Chlorotoloxy-ethyl phosphates
US3271314A (en) * 1958-12-04 1966-09-06 Ethyl Corp 2, 6-diisopropylphenol
GB1146173A (en) * 1966-06-18 1969-03-19 Geigy Uk Ltd Production of triaryl phosphates
US3723578A (en) * 1970-10-13 1973-03-27 Gaf Corp Phosphate esters of ethers of thiol substituted phenols
US4171272A (en) * 1977-12-02 1979-10-16 Fmc Corporation Turbine lubricant
FR2601259B1 (fr) * 1986-07-11 1990-06-22 Rhone Poulenc Chimie Nouvelles compositions tensio-actives a base d'esters phosphoriques leur procede de preparation et leur application a la formulation de matieres actives.
MY103951A (en) * 1988-01-12 1993-10-30 Kao Corp Detergent composition
US5091211A (en) * 1989-08-17 1992-02-25 Lord Corporation Coating method utilizing phosphoric acid esters
US5110503A (en) * 1990-05-15 1992-05-05 Elliot Cohen Demulsifying
JP2869186B2 (ja) * 1990-10-17 1999-03-10 株式会社トーメン 植物における生物活性剤の吸収移行を促進する方法及び組成物
NZ258610A (en) * 1992-12-11 1997-05-26 Smithkline Beecham Plc Various 4-acylamino-2h-benzo[b]pyran-3-ol derivatives;use in preparation of medicaments
US5646176A (en) * 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
KR960008645B1 (ko) * 1993-09-08 1996-06-28 동국제약 주식회사 오르토-이소프로필화 페놀 유도체의 제조방법
US5731355A (en) * 1994-03-22 1998-03-24 Zeneca Limited Pharmaceutical compositions of propofol and edetate
IT1270093B (it) * 1994-09-28 1997-04-28 Zambon Spa Processo per la purificazione di 2,6-diisopropilfenolo
US5804682A (en) * 1995-11-29 1998-09-08 Henkel Corporation Aqueous dispersions of polyamides
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations
US5723538A (en) * 1996-06-14 1998-03-03 Henkel Corporation Aqueous dispersions of polyamides
US5746973A (en) * 1996-07-10 1998-05-05 Naraghi; Ali Method for reducing odorant depletion
US6254853B1 (en) * 1998-05-08 2001-07-03 Vyrex Corporation Water soluble pro-drugs of propofol
US6204257B1 (en) * 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
EA004708B1 (ru) * 2000-02-04 2004-06-24 Эли Лилли Энд Компани Фармацевтическая композиция, включающая пеметрексед вместе с монотиоглицерином, l-цистеином или тиогликолевой кислотой
MXPA02011531A (es) * 2000-05-25 2003-04-25 Astrazeneca Ab Beneficio de superviviencia.
IN187686B (xx) * 2000-06-21 2002-06-08 Bharat Serums & Vaccines Ltd
US6362234B1 (en) * 2000-08-15 2002-03-26 Vyrex Corporation Water-soluble prodrugs of propofol for treatment of migrane
US7034013B2 (en) * 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin

Also Published As

Publication number Publication date
EP1458355B1 (en) 2009-05-06
MXPA04006325A (es) 2005-03-31
IL208697A0 (en) 2010-12-30
JP2010235622A (ja) 2010-10-21
RU2004119056A (ru) 2005-04-20
ATE430571T1 (de) 2009-05-15
ES2325918T3 (es) 2009-09-24
ZA200404616B (en) 2005-10-26
WO2003057153A3 (en) 2004-01-29
NO20042459L (no) 2004-08-25
KR20040080444A (ko) 2004-09-18
WO2003057153A2 (en) 2003-07-17
CA2470500A1 (en) 2003-07-17
AU2002364238B2 (en) 2007-01-18
JP2005517679A (ja) 2005-06-16
NO334424B1 (no) 2014-03-03
KR20100112632A (ko) 2010-10-19
PL205271B1 (pl) 2010-03-31
IL162692A (en) 2011-03-31
HK1069976A1 (en) 2005-06-10
CA2470500C (en) 2012-05-15
US20050042280A1 (en) 2005-02-24
DE60232271D1 (de) 2009-06-18
AU2002364238A1 (en) 2003-07-24
HU229293B1 (hu) 2013-10-28
HUP0500439A2 (hu) 2005-08-29
RU2316317C2 (ru) 2008-02-10
NZ533536A (en) 2006-11-30
CN1329036C (zh) 2007-08-01
PL372324A1 (en) 2005-07-11
EP1458355A4 (en) 2005-04-20
BR0215303A (pt) 2005-04-05
UA76802C2 (uk) 2006-09-15
EP1458355A2 (en) 2004-09-22
CN1607938A (zh) 2005-04-20

Similar Documents

Publication Publication Date Title
IL208697A0 (en) Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
DK1299348T3 (da) Forbindelser og sammensætninger til levering af aktive midler
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
DK1133316T3 (da) Adenovirus-formulering til genterapi
DK1273299T3 (da) Minoxidilinindeholdende praparater
WO2008045189A3 (en) Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
WO2002102351A3 (en) Compositions comprising a cationic homopolymer and their use for stabilization of an oxidizing solution
PT1589949E (pt) Composições liofilizadas estabilizadas compreendendo inibidor da coagulação por factores tecidulares ou variante de inibidor da coagulação por factores tecidulares
MEP24008A (en) Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
MXPA03011480A (es) Una preparacion farmaceutica acuosa de cilostazol para uso parenteral.
RS50046B (sr) Farmaceutske kompozicije tizoksanida i nitazoksanida
WO2003018059A3 (de) Kombinationspräparate von arylsubstituierten propanolaminderivaten mit weiteren wirkstoffen und deren verwendung
ATE367165T1 (de) Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen
MY138172A (en) Pharmaceutical compositions based on azetidine derivatives
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
GEP20094648B (en) Anti-parasiticidal composition
CO5261624A1 (es) Novedosos derivados fenilheteroalquilamina, procesos para su preparacion, composiciones farmaceuticas que comprenden dichos derivados novedosos y su uso en terapia
AU3548901A (en) Veterinary compositions for the treatment of parasitic diseases
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
WO2005011565A3 (fr) Vernis a ongles a action antimycosique
ATE301469T1 (de) Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase
MXPA04006269A (es) Composicion farmaceutica que comprende un inhibidor de alfa-glucosidasa y acido 4-oxobutanoico y uso de la misma para tratamiento de diabetes.
HRP20070054T3 (en) Fungicidal mixtures
GT200200171A (es) Formulaciones en combinacion de derivados de propanol-amina sustituidos con arilo, junto con otras sustancias activas y su utilizacion
ATE382363T1 (de) Pharmazeutische zusammensetzung enthaltend bulbophyllum

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed